Catalyst Wire Dossier Catalyst Wire Dossier

anti-VEGF

vascular endothelial growth factor inhibitor
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for anti-VEGF, covering 2017-04-11 to 2024-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy [Phase 4]

See pricing